Genetic profiling of CLL: a 'TP53 addict' perspective
Cell Death Dis
.
2016 Jan 14;7(1):e2042.
doi: 10.1038/cddis.2015.415.
Authors
L Lodé
1
,
F Cymbalista
2
3
4
,
T Soussi
5
6
7
Affiliations
1
Haematology Laboratory, UMR-CNRS-5235, CHU, F-34000 Montpellier, France.
2
INSERM U978, Bobigny, France.
3
Université Paris 13, Sorbonne Paris Cité, Labex 'Inflamex', Bobigny, France.
4
Service d'Hématologie Biologique, Hôpital Avicenne, AP-HP, Bobigny, France.
5
Sorbonne Université, UPMC Univ Paris 06, F- 75005 Paris, France.
6
Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska (CCK) R8:04, Stockholm SE-171 76, Sweden.
7
INSERM, U1138, Centre de Recherche des Cordeliers, Paris, France.
PMID:
26775696
PMCID:
PMC4816188
DOI:
10.1038/cddis.2015.415
No abstract available
Publication types
Comment
MeSH terms
Disease Progression*
Evolution, Molecular*
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
Mutation / genetics*
Neoplasm Recurrence, Local / genetics*